Papillary breast lesions are rare breast tumors that comprise a broad spectrum of diseases.
Pathologically they present as mass-like projections attached to the wall of the ducts …

Background Available retrospective data suggest the upgrade rate for intraductal papilloma
(IP) without atypia on core biopsy (CB) ranges from 0 to 12%, leading to variation in …

Please see the Editorial Comment by Shruthi Ram discussing this article. To listen to the
podcast associated with this article, please select one of the following: iTunes, Google Play …

Background The cytologic diagnosis of papillary lesions of the breast is challenging
because of the diverse morphology, including epithelial hyperplasia, atypia, low‐grade …

Abstract Purpose When Core Needle Biopsy (CNB) demonstrates Atypical Ductal
Hyperplasia (ADH), Flat Epithelial Atypia (FEA), Intraductal Papilloma (IDP), or Radial …

Background Current standard management for intraductal papilloma (IDP) diagnosed at
biopsy indicates complete surgical resection, but there are increasing controversies over …

Background Management of breast lesions of uncertain malignant potential diagnosed at
core needle biopsy (CNB) is controversial due to variable upstage rate (UR) with surgical …

Objective To compare outcomes between benign intraductal papillomas diagnosed on core
need biopsy that were excised (BIP-E) versus those that were followed-up (BIP-F) at our …

Background There is uncertainty whether benign breast papillomas without atypia (BP) can
be followed by imaging or require surgical resection. Methods A single-center, retrospective …

Aim In this study, we analyzed the upgrade rate and associated factors for upgrade,
malignant upgrade, and subsequent breast cancer occurrence of papillary breast lesions …